ARKRAY USA is a health care company headquartered in the United States. With a history dating back to 1960, the company has established itself as a leader in diabetes health solutions, living up to its slogan, "Your Diabetes Health Ally." ARKRAY has a rich legacy of over 50 years of commitment to producing safe, reliable, and effective products. This commitment is evident in its track record of innovation, from developing the world's first HbA1c Analyzer to pioneering the first blood glucose monitoring system for Long-Term Care. Today, ARKRAY continues to make its mark by manufacturing cost-effective diabetes care products and clinical chemistry equipment that are marked by their simplicity, convenience, and ease of use. Additionally, the company has positioned itself as a private-label blood glucose meter manufacturer for the world's largest retailer. This diversification has expanded its reach and impact within the market. What sets ARKRAY apart is its unwavering dedication to customer service, with personalized training, industry expertise, and ongoing support. This commitment to customer satisfaction has established the company as a true partner in diabetes management. While details about its last investment and the involved investors remain undisclosed, ARKRAY's strong presence and reputation in the industry position it as an attractive prospect for potential investors seeking opportunities in the evolving health care market.
There is no investment information
No recent news or press coverage available for ARKRAY USA.